This year, GBG is represented at the DKK with three scientific posters, presenting current results from its study activities.
At the 48th San Antonio Breast Cancer Symposium 2025 GBG is taking part in the following presentations.
GBG @ ESMO 2025 in Berlin!
Go ahead and get tested!
A groundbreaking analysis from the ASCENT study investigates, for the first time, the impact of Body Mass Index (BMI) on treatment outcomes in mTNBC patients
The ICH-GCP E6 guideline has been updated and will come into force on 25-July-2025 as Release 3 (R3) in the EU region, with Switzerland following suit.
